View the DACOMAKS 45 registration information details.
Back to drug list
ItemsDrug Registration information
ID902
No902
Brand NameDACOMAKS 45
IngredientsDACOMITINIB 45 MG
Dosage FormTABLET
Primary PackagingBOTTLE
Storage
Shelf Life3 YEARS
Pack Size30 TABLETS/BOTTLE
Dispensing Category
ATC Classification
Pharmaceutical Class
IndicationsFOR FIRSTLINE TREATMENT OF PATIENTS WITH METASTATIC NON SMALL CELL LUNG CANCER WITH EPIDERMAL GROWTH FACTOR RECEPTOR EXON 19 DELETION OR EXON 21 L858R SUBSTITUTION MUTATION
Contraindications
Side Effects
Unit Price
EDLNULL
DescriptionBLUE ROUND, FILM COATED TABLET
Note
License OwnerFACTORY NO.2
ManufacturerFACTORY NO. 2
CountryLAOS
Import Registration No
Import Registration Date
ActivityCERTIFICATE RELEASED
Applied Date
FDD Registration No12 L 1275/24
FDD Registration Date13/01/2025
Expiry Date12/01/2030
Back to drug list
ADB ASEAN COVID-19 Laos JICA KOICA Global Fund WFP UHS Laos World Bank MOH Laos UNODC WHO SIDA